Autonomous Skin Cancer Detection Arrives on Smartphones

Skin Analytics has introduced DERM Zero, the world’s first Class-III, CE-marked AI medical device capable of autonomously assessing skin cancer using nothing more than a standard smartphone, marking a major step forward in digital healthcare and early cancer detection. DERM Zero enables healthcare providers to deliver clinical-grade skin cancer assessments within seconds without requiring hospital appointments, specialist imaging equipment, or dermatologist reviews.